Discussion about this post

User's avatar
Ype's avatar

Thank you for writing the article. Campine is a rather unknown Belgium company and it is good to have some research on it. Last year results were "depressed" by the activation of a strategic (1 month) reserve of antimonytrioxide. Many people see this as a revolving stockpile of antimony emptied in 1 month of production but this was anything but that. On the balance sheet this reserve was activated as as a tangible asset for €8,25mln (not to be marked-to-market if prices move upward!!)...at the end of the year this was far more worth than €8,25mln and thus a hidden reserve. I think this move was done not in january but and the end of H1 to dampen the outstanding results (otherwise it would have been a profit on stockpile). So bear in mind that 2024 was much better than reported and that 2025 had a very promising start. Conclusion for me is that the board of Campine's statement about what kind of results to expect for 2025 is one of deeply underpromise and easy to overdeliver.

Expand full comment
PPinvest's avatar

Thanks, another very good article. What are the arguments against the thesis that EBITDA in the specialty chemicals segment will triple again in 2025 if antimony prices double to an average of 46,000 in 2025?

Expand full comment
8 more comments...

No posts